Mitochondria-Targeted Fluorescent Probe for Super-Resolution Imaging of HNO in Lung Cancer
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.6c01116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Xiuxiu Yue und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Environment and Biological Engineering, Wuhan Technology and Business University, Wuhan 430065, China. Hauptthemen laut MEDLINE: Nitrogen Oxides, Mitochondria, Fluorescent Dyes, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Hubei Province, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Lung cancer is a leading cause of cancer-related mortality globally, with complex biochemical processes underlying its initiation and progression. Nitroxyl (HNO), a reactive nitrogen species with unique chemical and biological properties, has emerged as a potential regulator of tumor biology. However, the transient nature and intertwined pathways of HNO with nitric oxide (NO) pose significant challenges for precise, real-time detection at the subcellular level, particularly within the mitochondrial key sites where HNO is generated and utilized. Herein, a mitochondria-targeted fluorescent probe (DCPH) was designed and synthesized for the super-resolution imaging of HNO. DCPH demonstrates high sensitivity and selectivity for HNO, with stable performance across the physiological pH range. Super-resolution imaging confirms the mitochondria-targeting capability of DCPH, which enables the visualization of both exogenous and endogenous HNO in A549 cells. This probe is capable of successfully monitoring HNO dynamics under inflammatory stimulation and during NO/H2S crosstalk. Furthermore, in vivo imaging in tumor-bearing mice demonstrates that DCPH can visually track HNO production during sodium nitroprusside (SNP) treatment, which is correlated with significant tumor growth inhibition. Overall, DCPH provides a novel tool for the high-resolution detection of mitochondrial HNO and offers insights into the biological functions of HNO in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Environment and Biological Engineering, Wuhan Technology and Business University, Wuhan 430065, China.
- Shandong Provincial Key Laboratory of Tumor Imaging Equipment Development and Integrated Diagnosis and Treatment Technology, College of Medicine, Linyi University, Linyi 276000, China.
ORCID-Profile: Pengfei Shi, Shusheng Zhang, Lei Yang
Förderung
- Natural Science Foundation of Hubei Province
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Development Plan of the Youth Innovation Team in Colleges and Universities of Shandong Province
Zitieren
APA
Yue, X., Li, M., Li, W., Liu, M., Liu, C., Yang, J., Wang, Q., Shi, P., Zhang, S., & Yang, L. (2026). Mitochondria-Targeted Fluorescent Probe for Super-Resolution Imaging of HNO in Lung Cancer. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c01116
Vancouver
Yue X, Li M, Li W, Liu M, Liu C, Yang J, et al. Mitochondria-Targeted Fluorescent Probe for Super-Resolution Imaging of HNO in Lung Cancer. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c01116
BibTeX
@article{Yue2026,
author = {Yue, Xiuxiu and Li, Mei and Li, Wenwen and Liu, Miaomiao and Liu, Chenxi and Yang, Jiaxin and Wang, Qing and Shi, Pengfei and Zhang, Shusheng and Yang, Lei},
title = {Mitochondria-Targeted Fluorescent Probe for Super-Resolution Imaging of HNO in Lung Cancer},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c01116}
}
EUVIMED